Literature DB >> 20569553

Exclusion of a cavernous aneurysm by leo stent.

J M Pumar1, J A Castiñeira, F Vazquez, M Blanco, P Lylyk.   

Abstract

SUMMARY: The Leo stent is a cranial self-expanding stent recently developed for the treatment of wideneck aneurysms.We report the first case with total occlusion of a cavernous aneurysm nine months after stent placement without complementary coiling.

Entities:  

Year:  2006        PMID: 20569553      PMCID: PMC3355360          DOI: 10.1177/159101990601200111

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  9 in total

1.  The formation and regression of a flow-related cerebral artery aneurysm.

Authors:  P Senn; J K Krauss; L Remonda; N Godoy; G Schroth
Journal:  Clin Neurol Neurosurg       Date:  2000-09       Impact factor: 1.876

2.  Endovascular treatment of giant and large intracranial aneurysms by using a combination of stent placement and liquid polymer injection.

Authors:  Michel E Mawad; Saruhan Cekirge; Elisa Ciceri; Isil Saatci
Journal:  J Neurosurg       Date:  2002-03       Impact factor: 5.115

Review 3.  The emerging concept of vascular remodeling.

Authors:  G H Gibbons; V J Dzau
Journal:  N Engl J Med       Date:  1994-05-19       Impact factor: 91.245

4.  Anatomically shaped internal carotid artery aneurysm in vitro model for flow analysis to evaluate stent effect.

Authors:  Krisztina Baráth; Francis Cassot; Daniel A Rüfenacht; Jean H D Fasel
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

5.  Treatment of internal carotid artery aneurysms with a covered stent: experience in 24 patients with mid-term follow-up results.

Authors:  Isil Saatci; H Saruhan Cekirge; M Halil Ozturk; Anil Arat; Fikret Ergungor; Zeki Sekerci; Engin Senveli; Uygur Er; Sami Turkoglu; Osman E Ozcan; Tuncalp Ozgen
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

6.  Broad-based intracranial aneurysms: thrombosis induced by stent placement.

Authors:  Ritva Vanninen; Hannu Manninen; Antti Ronkainen
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

7.  Percutaneous intracranial stent placement for aneurysms.

Authors:  Patrick P Han; Felipe C Albuquerque; Francisco A Ponce; Christopher I MacKay; Joseph M Zabramski; Robert F Spetzler; Cameron G McDougall
Journal:  J Neurosurg       Date:  2003-07       Impact factor: 5.115

8.  Spontaneous regression of two supraophthalmic internal cerebral artery aneurysms following flow pattern alteration.

Authors:  F J Hans; T Krings; M H T Reinges; M Mull
Journal:  Neuroradiology       Date:  2004-05-19       Impact factor: 2.804

9.  Endovascular reconstruction of intracranial arteries by stent placement and combined techniques.

Authors:  Pedro Lylyk; José E Cohen; Rosana Ceratto; Angel Ferrario; Carlos Miranda
Journal:  J Neurosurg       Date:  2002-12       Impact factor: 5.115

  9 in total
  4 in total

1.  Treatment of intracranial aneurysms using flow-diverting silk stents (BALT): a single centre experience.

Authors:  M Leonardi; L Cirillo; F Toni; M Dall'olio; C Princiotta; A Stafa; L Simonetti; R Agati
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

2.  LEO stent monotherapy for the endovascular reconstruction of fusiform aneurysms of the middle cerebral artery.

Authors:  J M Pumar; I Lete; M I Pardo; F Vázquez-Herrero; M Blanco
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

3.  Long-term occlusion results with SILK flow diversion in 28 aneurysms: Do recanalizations occur during follow-up?

Authors:  Anastasios Mpotsaris; Martin Skalej; Oliver Beuing; Bernd Eckert; Daniel Behme; Werner Weber
Journal:  Interv Neuroradiol       Date:  2015-05-26       Impact factor: 1.610

4.  Complications in the treatment of intracranial aneurysms with silk stents: an analysis of 30 consecutive patients.

Authors:  L Cirillo; M Leonardi; M Dall'olio; C Princiotta; A Stafa; L Simonetti; F Toni; R Agati
Journal:  Interv Neuroradiol       Date:  2012-12-03       Impact factor: 1.610

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.